Stock ALA AROVELLA THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Arovella Therapeutics Limited

Equities

ALA

AU0000182784

Delayed Australian S.E.
Other stock markets
 02:25:38 13/05/2024 BST 		5-day change 1st Jan Change
0.12 AUD 0.00% Intraday chart for Arovella Therapeutics Limited -4.00% +4.35%
03-26 Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise MT
03-20 Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arovella Therapeutics Appoints CFO
MT
Arovella Therapeutics Limited Announces Changes to its Board
CI
Arovella Therapeutics Limited Announces Retirement of David Simmonds as Non-Executive Director
CI
Arovella Therapeutics Appoints Nonexecutive Chair
MT
Arovella Therapeutics Appoints COO
MT
Arovella Therapeutics Ltd Appoints Dr. Nicole Van Der Weerden as Chief Operating Officer, January 4, 2023
CI
Arovella Therapeutics Ltd Appoints Gary Phillips as an Independent Non-Executive Director
CI
Arovella Therapeutics Ltd Announces Executive Changes
CI
Arovella Therapeutics Ltd Announces Appointment of Elizabeth Stoner as Non-Executive Director
CI
Arovella Therapeutics Ltd Announces Executive Changes
CI
Suda Pharmaceuticals : Changes Name to Arovella Therapeutics; Shares Jump 4%
MT
SUDA Pharmaceuticals Ltd Appoints John Maher to Scientific Advisory Board
CI
SUDA Pharmaceuticals Ltd Appoints Reuben Benjamin to Scientific Advisory Board
CI
Suda Pharmaceuticals Ltd Announces Appointment of Dr. Debora Barton as Non-Executive Director
CI
Suda Pharmaceuticals Ltd Appoints Professor Gunnar Birgegård as Scientific Advisory Board
CI
Suda Pharmaceuticals Ltd Appoints of Dr. Anil K. Sood to its Scientific Advisory Board
CI
Tony Macintyre and Michael Baker to Assume the Role of Chief Technical Officer of Suda Pharmaceuticals Ltd
CI
Suda Pharmaceuticals Ltd Announces Executive Changes
CI
Suda Pharmaceuticals Ltd Appoints Phillip Hains as Joint Company Secretary
CI
Suda Pharmaceuticals Ltd Appoints Michael Baker as A Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALA Stock
  4. News Arovella Therapeutics Limited
  5. Insiders